Sophie Steeland

1.0k total citations · 1 hit paper
12 papers, 775 citations indexed

About

Sophie Steeland is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sophie Steeland has authored 12 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 4 papers in Molecular Biology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sophie Steeland's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (2 papers) and Toxin Mechanisms and Immunotoxins (2 papers). Sophie Steeland is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (2 papers) and Toxin Mechanisms and Immunotoxins (2 papers). Sophie Steeland collaborates with scholars based in Belgium, Germany and United States. Sophie Steeland's co-authors include Roosmarijn E. Vandenbroucke, Claude Libert, Elien Van Wonterghem, Griet Van Imschoot, Riet De Rycke, Leen Puimège, Filip Van Hauwermeiren, Jurgen Haustraete, Paco Hulpiau and Nick Devoogdt and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Scientific Reports.

In The Last Decade

Sophie Steeland

12 papers receiving 764 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nanobodies as therapeutics: big opportunities for small antibodies

2016 349 citations Sophie Steeland, Roosmarijn E. Vandenbroucke et al. Drug Discovery Today profile →

Peers

Countries citing papers authored by Sophie Steeland

Since Specialization

Citations

This map shows the geographic impact of Sophie Steeland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sophie Steeland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sophie Steeland more than expected).

Fields of papers citing papers by Sophie Steeland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sophie Steeland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sophie Steeland. The network helps show where Sophie Steeland may publish in the future.

Co-authorship network of co-authors of Sophie Steeland

This figure shows the co-authorship network connecting the top 25 collaborators of Sophie Steeland. A scholar is included among the top collaborators of Sophie Steeland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sophie Steeland. Sophie Steeland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	A Study of Cecal Ligation and Puncture-Induced Sepsis in Tissue-Specific Tumor Necrosis Factor Receptor 1-Deficient Mice 2019 ·Frontiers in Immunology ·Jolien Vandewalle, Sophie Steeland, (unknown), Melanie Eggermont, Elien Van Wonterghem, Roosmarijn E. Vandenbroucke, Claude Libert	15
2	Choroid plexus tumor necrosis factor receptor 1: A new neuroinflammatory piece of the complex Alzheimer’s disease puzzle 2019 ·Neural Regeneration Research ·Roosmarijn E. Vandenbroucke, Sophie Steeland	7
3	Counteracting the effects of TNF receptor‐1 has therapeutic potential in Alzheimer's disease 2018 ·EMBO Molecular Medicine ·Sophie Steeland, Nina Gorlé, Charysse Vandendriessche, Sriram Balusu, Marjana Brkić, Caroline Van Cauwenberghe, Griet Van Imschoot, Elien Van Wonterghem, Riet De Rycke, (unknown), Saskia Lippens, Edward G. Stopa, Conrad E. Johanson, Claude Libert, Roosmarijn E. Vandenbroucke	90
4	A New Venue of TNF Targeting 2018 ·International Journal of Molecular Sciences ·Sophie Steeland, Claude Libert, Roosmarijn E. Vandenbroucke	103
5	TNFR1 inhibition with a Nanobody protects against EAE development in mice 2017 ·Scientific Reports ·Sophie Steeland, (unknown), Griet Van Imschoot, Riet De Rycke, Wendy Toussaint, Leen Vanhoutte, Christian Vanhove, Filip De Vos, Roosmarijn E. Vandenbroucke, Claude Libert	43
6	Simultaneous Inhibition of Tumor Necrosis Factor Receptor 1 and Matrix Metalloproteinase 8 Completely Protects Against Acute Inflammation and Sepsis 2017 ·Critical Care Medicine ·Sophie Steeland, (unknown), Jolien Vandewalle, Marlies Ballegeer, Elien Van Wonterghem, Melanie Eggermont, Johan Decruyenaere, Liesbet De Bus, Claude Libert, Roosmarijn E. Vandenbroucke	14
7	Nanobodies as therapeutics: big opportunities for small antibodies breakdown → 2016 ·Drug Discovery Today ·Sophie Steeland, Roosmarijn E. Vandenbroucke, Claude Libert	349
8	Development and Validation of a Small Single-domain Antibody That Effectively Inhibits Matrix Metalloproteinase 8 2016 ·Molecular Therapy ·Delphine Demeestere, Eline Dejonckheere, Sophie Steeland, Paco Hulpiau, Jurgen Haustraete, Nick Devoogdt, Rielana Wichert, Christoph Becker‐Pauly, Elien Van Wonterghem, Sylviane Dewaele, Griet Van Imschoot, Jeroen Aerts, Lut Arckens, Yvan Saeys, Claude Libert, Roosmarijn E. Vandenbroucke	19
9	Topical imiquimod yields systemic effects due to unintended oral uptake 2016 ·Scientific Reports ·Lynda Grine, Sophie Steeland, (unknown), Marlies Ballegeer, Stefan Lienenklaus, Siegfried Weiß, Niek N. Sanders, Roosmarijn E. Vandenbroucke, Claude Libert	32
10	Efficient analysis of mouse genome sequences reveal many nonsense variants 2016 ·Proceedings of the National Academy of Sciences ·Sophie Steeland, Steven Timmermans, (unknown), Paco Hulpiau, Yvan Saeys, Marc Van Montagu, Roosmarijn E. Vandenbroucke, Claude Libert	4
11	Glucocorticoid‐induced microRNA‐511 protects against TNF by down‐regulating TNFR 1 2015 ·EMBO Molecular Medicine ·Leen Puimège, Filip Van Hauwermeiren, Sophie Steeland, (unknown), Jolien Vandewalle, Sofie Lodens, Lien Dejager, Sofie Vandevyver, Jan Staelens, Steven Timmermans, Roosmarijn E. Vandenbroucke, Claude Libert	33
12	Generation and Characterization of Small Single Domain Antibodies Inhibiting Human Tumor Necrosis Factor Receptor 1 2014 ·Journal of Biological Chemistry ·Sophie Steeland, Leen Puimège, Roosmarijn E. Vandenbroucke, Filip Van Hauwermeiren, Jurgen Haustraete, Nick Devoogdt, Paco Hulpiau, Geert Leroux‐Roels, Debby Laukens, Philip Meuleman, Martine De Vos, Claude Libert	66

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact